Dr. Steven Bennett Chinn, MD

Dr. Chinn practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health.

Dr. Chinn's NPI, 1619130333, was assigned on July 2, 2008. Dr. Chinn graduated from University of Southern California Keck School of Medicine in 2004. Dr. Chinn holds Michigan license 4301091967.

Dr. Chinn's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth, at 100 Michigan St NE, Grand Rapids, MI 49503 in Kent County. The practice phone is (616) 391-1774.

Dr. Chinn's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health. Dr. Chinn is also affiliated with University Hospital. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Chinn to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chinn practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Chinn's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Chinn is licensed in Michigan.

CMS data shows 387 Medicare services from Dr. Chinn across 7 procedure codes in 2024, for 171 Medicare patients. Medicare paid $37,474 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 171 Medicare patients who saw Dr. Chinn in 2024. The largest group is 65 to 74, with 84 patients. 65% of them have high blood pressure, and 58% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chinn's median patient age at 66, with 38% women.

In 2024, Dr. Chinn wrote 329 Medicare Part D claims for 88 patients. 86% of them were for generic drugs. CMS names the drug for 258 of them, across 6 drugs with 11 or more claims each, at $6,481 in total drug cost. In 2023, CMS named 248 claims across 6 drugs.

Dr. Chinn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chinn as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 102 papers to Dr. Chinn, published from 2012 to 2024. 2023 was the busiest year, with 12. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Squamous Cell Carcinoma of Head and Neck. Dr. Chinn has published most often in Head Neck. Dr. Chinn's most frequent co-authors are Matthew Edward Spector, MD, Keith Andrew Casper, MD and Andrew J. Rosko, MD.

Dmand AI links Dr. Chinn to 1 clinical trial. Conditions studied include Mouth Neoplasms and Mouth Diseases.

CMS Open Payments shows 13 general payments to Dr. Chinn from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. DePuy Synthes Sales Inc. paid the most, $337.

Dr. Chinn graduated from University of Southern California Keck School of Medicine in 2004.